Instrument Inactif

Autres langues Immunoprecise Antibodies Ltd Other OTC

Actions

CA87588T1030

Produits pharmaceutiques

Autres langues

01/10	MindWalk Holdings Corp. Announces Appointment of Kim Remizowski as Independent Director, Audit Committee Member and Compensation, Nomination and Governance Committee Member, Effective September 29, 2026
01/10	AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
01/10	MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director
21/09	Mindwalk Holdings Corp. Brings Openfold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
21/09	MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
14/09	MindWalk Fiscal Q1 Loss Widens, Revenue Rises
14/09	MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
14/09	MindWalk Holdings Corp. Reports Earnings Results for the First Quarter Ended July 31, 2026
14/09	AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
14/09	MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
14/09	Mindwalk Holdings Corp. Enters into Binding Commitment for USD 30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
10/09	MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08/09	MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
03/09	The Market Just Told You Which Layer Of AI Biology It Is Paying For
19/08	Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
10/08	AI Found an Influenza Target That Survives Viral Mutation
27/07	A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
24/07	A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
23/07	MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
23/07	Tranche Update on MindWalk Holdings Corp.'s Equity Buyback Plan announced on October 9, 2025.
23/07	MindWalk Holdings Corp. Reports Fiscal 2026 Results, Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
23/07	An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
23/07	MindWalk : Annual Report for Fiscal Year Ending April 30, 2026 (Form 20-F)
23/07	MindWalk Holdings Corp. Auditor Raises 'Going Concern' Doubt
22/07	MindWalk Holdings Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2026